Products for Research Use Only
RegisterLogin

Solanezumab

CAT: 0804-HY-P99317-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99317-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1].
CAS Number
955085-14-0
Product Name Alternative
LY-2062430
UNSPSC
12352203
Target
Amyloid-β
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/solanezumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Solanezumab]
Molecular Weight
(144.8 kDa)
References & Citations
[1][1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. N Engl J Med. 2018 Jan 25;378 (4) :321-330.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T76827-01Solanezumab
GTR18337953-01Solanezumab Antibody
MBS1563394-01Research Grade Solanezumab
E55B0518Solanezumab (Reference antibody)
ICH5871-20mgSolanezumab Biosimilar - Research Grade
GTR18780742-01(Solanezumab) Biosimilar Reference Antibody
C00781-1mgSolanezumab (Anti-Amyloid Beta)
A138561Solanezumab Biosimilar (Monoclonal, IgG1)
GTR18697662-01Solanezumab Human Monoclonal Antibody
048048Amyloid Beta (solanezumab) discontinued

Popular Products